Matches in Nanopublications for { ?s ?p "[These findings indicate that downregulation of IDO controls ovarian cancer progression by activating NK cells, suggesting IDO targeting as a potential therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP332304.RAvHjq8VWT7QKwFatzu7Tn4izEr1yUSN666IftQODjjSA130_assertion description "[These findings indicate that downregulation of IDO controls ovarian cancer progression by activating NK cells, suggesting IDO targeting as a potential therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332304.RAvHjq8VWT7QKwFatzu7Tn4izEr1yUSN666IftQODjjSA130_provenance.
- assertion description "[These findings indicate that downregulation of IDO controls ovarian cancer progression by activating NK cells, suggesting IDO targeting as a potential therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These findings indicate that downregulation of IDO controls ovarian cancer progression by activating NK cells, suggesting IDO targeting as a potential therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP947543.RAbxveJEtOxXvL_dKNmSclRo9Iv7AqQNHs6K8KP36NTsE130_assertion description "[These findings indicate that downregulation of IDO controls ovarian cancer progression by activating NK cells, suggesting IDO targeting as a potential therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947543.RAbxveJEtOxXvL_dKNmSclRo9Iv7AqQNHs6K8KP36NTsE130_provenance.
- NP509632.RAmALktbP87MRm_j--Oq8QRefcw-NrHgaiKuIwD6uXDJ8130_assertion description "[These findings indicate that downregulation of IDO controls ovarian cancer progression by activating NK cells, suggesting IDO targeting as a potential therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509632.RAmALktbP87MRm_j--Oq8QRefcw-NrHgaiKuIwD6uXDJ8130_provenance.
- NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_assertion description "[These findings indicate that downregulation of IDO controls ovarian cancer progression by activating NK cells, suggesting IDO targeting as a potential therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_provenance.
- NP947544.RA5NXFNJa-jEzXEPCDxMSc9k2s6mperUF9P5AnEL6e_LA130_assertion description "[These findings indicate that downregulation of IDO controls ovarian cancer progression by activating NK cells, suggesting IDO targeting as a potential therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947544.RA5NXFNJa-jEzXEPCDxMSc9k2s6mperUF9P5AnEL6e_LA130_provenance.